AGT and metabolic dysfunction-associated steatotic liver disease: Patients with NAFLD present elevated ANG II levels [4,5], and animals with liver steatosis show increased hepatic expression of AGT, AGT II and ANG II type 1 receptor (AT1R) [6,7].